膜杰作
Star Staining
- Genetically modified cell lines best reflect MOA (Mechanism of Action)
- Higher activity and larger assay window for robust and reproducible cell-based bioassay
- Comprehensive application data to support assay development and validation
- Full tracible record, stringent quality control and validated cell passage stability
- Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
- Global commercial license assistance whenever regulatory filing is required
描述（Description）
The Human NKp46 (Luc) Jurkat Reporter Cell was engineered to not only express the NFAT response element driving luciferase expressing systems, but also express the receptor full length human NKp46 (Gene ID: 9437). When cocultured with anti-human Nkp46 agonist antibody, the interaction of agonist antibody and NKp46 on the surface of Human NKp46 (Luc) Jurkat Reporter Cell results in NFAT-mediated luminescence.
应用说明（Application）
• Screen for anti-human NKp46 agonist antibody.
生长特性（Growth Properties）
Suspension
筛选标记（Selection Marker）
Puromycin (5 μg/mL) + Hygromycin (20 μg/mL)
培养基（Complete Growth Medium）
RPMI-1640 + 10% FBS
冻存液（Freeze Medium）
Serum-free cell cryopreservation medium
装量（Quantity）
1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium
存储（Storage）
Frozen in liquid nitrogen.
支原体检测（Mycoplasma Testing）
Negative
无菌检测（Sterility Testing）
Negative
使用说明（Instructions for Use）
See data sheet for detailed culturing and assay protocol.
质量管理控制体系（QMS）
Receptor Assay
Expression analysis of human NKp46 on Human NKp46 (Luc) Jurkat Reporter Cell by FACS.
Cell surface staining was performed on Human NKp46 (Luc) Jurkat Reporter Cell or negative control cell using APC- labeled Anti-human NKp46 antibody.
Protocol
Application
Agonistic activity analysis of anti-human NKp46 antibody (RLU).
This reporter cell was incubated with serial dilutions of anti-human NKp46 antibody. The EC50 of anti-human NKp46 antibody was approximately 0.1011 μg/mL.
Protocol
Agonistic activity analysis of anti-human NKp46 antibody (FOLD).
This reporter cell was incubated with serial dilutions of anti-human NKp46 antibody. The max induction fold was approximately 20.61.
Protocol
Passage Stability
Passage stability analysis by Signaling Bioassay.
The continuously growing Human NKp46 (Luc) Jurkat Reporter Cell was stimulated with serial dilutions of anti-human NKp46 antibody. Anti-human NKp46 antibody stimulated response demonstrates passage stabilization (fold induction and EC50) across passage 6-21.
Protocol
如有相关细胞池需求请联系我们
产品推荐（Recommended Products）
背景（Background）
Natural cytotoxicity triggering receptor 1 (NCR1) is also known as Natural killer cell p46-related protein (NK-p46), Lymphocyte antigen 94 homolog (LY94), CD antigen CD335, which belongs to the natural cytotoxicity receptor (NCR) family. NCR1 contains two Ig-like (immunoglobulin-like) domains. NCR1 interacts with CD247 and FCER1G. NCR1 / CD335 may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.
Limited Use&License Disclosure
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE FOLLOWING TERMS OF LIMITED USE OF THIS CELL LINE PRODUCT.
- If the researcher is not willing to accept the terms of limited use of this cell line product, and the product is unused, ACRO will accept return of the unused product.
- Researchers may use this product for research use only, no commercial use is allowed. "Commercial use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research.
- This cell line is neither intended for any animal or human therapeutic purposes nor for any direct human in vivo use . You have no right to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
- ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
- ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
- Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order.cn@acrobiosystems.com for further details.
